nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A1—kidney cancer	0.21	0.653	CbGaD
Albendazole—TUBA1A—Vinblastine—kidney cancer	0.179	0.325	CbGbCtD
Albendazole—ABCB1—kidney cancer	0.111	0.347	CbGaD
Albendazole—TUBB4B—Paclitaxel—kidney cancer	0.0778	0.141	CbGbCtD
Albendazole—TUBB4B—Vinblastine—kidney cancer	0.0683	0.124	CbGbCtD
Albendazole—TUBB4B—Vincristine—kidney cancer	0.0671	0.122	CbGbCtD
Albendazole—ABCB1—Temsirolimus—kidney cancer	0.0161	0.0293	CbGbCtD
Albendazole—CYP1A1—Erlotinib—kidney cancer	0.0155	0.0281	CbGbCtD
Albendazole—CYP3A4—Everolimus—kidney cancer	0.0143	0.026	CbGbCtD
Albendazole—CYP1A2—Pazopanib—kidney cancer	0.0097	0.0176	CbGbCtD
Albendazole—CYP3A4—Temsirolimus—kidney cancer	0.00967	0.0176	CbGbCtD
Albendazole—ABCB1—Pazopanib—kidney cancer	0.00848	0.0154	CbGbCtD
Albendazole—ABCB1—Dactinomycin—kidney cancer	0.00776	0.0141	CbGbCtD
Albendazole—CYP1A2—Erlotinib—kidney cancer	0.00692	0.0126	CbGbCtD
Albendazole—ABCB1—Gemcitabine—kidney cancer	0.00613	0.0111	CbGbCtD
Albendazole—ABCB1—Erlotinib—kidney cancer	0.00605	0.011	CbGbCtD
Albendazole—CYP1A2—Sorafenib—kidney cancer	0.00563	0.0102	CbGbCtD
Albendazole—ABCB1—Paclitaxel—kidney cancer	0.00554	0.0101	CbGbCtD
Albendazole—CYP3A4—Pazopanib—kidney cancer	0.00508	0.00923	CbGbCtD
Albendazole—ABCB1—Sorafenib—kidney cancer	0.00492	0.00894	CbGbCtD
Albendazole—ABCB1—Vinblastine—kidney cancer	0.00486	0.00883	CbGbCtD
Albendazole—ABCB1—Vincristine—kidney cancer	0.00478	0.00868	CbGbCtD
Albendazole—ABCB1—Sunitinib—kidney cancer	0.00399	0.00724	CbGbCtD
Albendazole—CYP3A4—Erlotinib—kidney cancer	0.00363	0.00659	CbGbCtD
Albendazole—CYP3A4—Paclitaxel—kidney cancer	0.00332	0.00603	CbGbCtD
Albendazole—ABCB1—Doxorubicin—kidney cancer	0.00299	0.00543	CbGbCtD
Albendazole—CYP3A4—Sorafenib—kidney cancer	0.00295	0.00536	CbGbCtD
Albendazole—CYP3A4—Vinblastine—kidney cancer	0.00291	0.00529	CbGbCtD
Albendazole—CYP3A4—Vincristine—kidney cancer	0.00286	0.0052	CbGbCtD
Albendazole—CYP3A4—Sunitinib—kidney cancer	0.00239	0.00434	CbGbCtD
Albendazole—CYP1A2—urine—kidney cancer	0.00216	0.101	CbGeAlD
Albendazole—TUBA1A—Zalcitabine—Gemcitabine—kidney cancer	0.00215	0.826	CbGdCrCtD
Albendazole—CYP3A4—Doxorubicin—kidney cancer	0.00179	0.00325	CbGbCtD
Albendazole—CYP3A4—urine—kidney cancer	0.00156	0.0733	CbGeAlD
Albendazole—TUBA1A—nephron tubule—kidney cancer	0.00153	0.0721	CbGeAlD
Albendazole—TUBA1A—renal system—kidney cancer	0.00139	0.0655	CbGeAlD
Albendazole—TUBA1A—kidney—kidney cancer	0.00135	0.0633	CbGeAlD
Albendazole—TUBA1A—cortex of kidney—kidney cancer	0.00131	0.0617	CbGeAlD
Albendazole—TUBA1A—gonad—kidney cancer	0.00125	0.0587	CbGeAlD
Albendazole—TUBA1A—cardiac atrium—kidney cancer	0.00125	0.0587	CbGeAlD
Albendazole—TUBB4B—nephron tubule—kidney cancer	0.00102	0.048	CbGeAlD
Albendazole—Mebendazole—CYP1A1—kidney cancer	0.000965	0.653	CrCbGaD
Albendazole—TUBB4B—renal system—kidney cancer	0.00093	0.0437	CbGeAlD
Albendazole—TUBB4B—kidney—kidney cancer	0.000899	0.0422	CbGeAlD
Albendazole—TUBB4B—cortex of kidney—kidney cancer	0.000875	0.0411	CbGeAlD
Albendazole—TUBB4B—gonad—kidney cancer	0.000834	0.0391	CbGeAlD
Albendazole—TUBB4B—cardiac atrium—kidney cancer	0.000832	0.0391	CbGeAlD
Albendazole—CYP1A2—renal system—kidney cancer	0.000528	0.0248	CbGeAlD
Albendazole—CYP1A1—renal system—kidney cancer	0.00052	0.0244	CbGeAlD
Albendazole—Mebendazole—ABCB1—kidney cancer	0.000513	0.347	CrCbGaD
Albendazole—CYP1A1—kidney—kidney cancer	0.000503	0.0236	CbGeAlD
Albendazole—CYP1A1—cardiac atrium—kidney cancer	0.000466	0.0219	CbGeAlD
Albendazole—TUBA1A—Azacitidine—Gemcitabine—kidney cancer	0.000452	0.174	CbGdCrCtD
Albendazole—Urinary tract disorder—Erlotinib—kidney cancer	0.000409	0.00521	CcSEcCtD
Albendazole—Urethral disorder—Erlotinib—kidney cancer	0.000406	0.00517	CcSEcCtD
Albendazole—Pancytopenia—Dactinomycin—kidney cancer	0.000402	0.00513	CcSEcCtD
Albendazole—Thrombocytopenia—Temsirolimus—kidney cancer	0.000401	0.00511	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Pazopanib—kidney cancer	0.0004	0.00509	CcSEcCtD
Albendazole—Skin disorder—Temsirolimus—kidney cancer	0.000398	0.00507	CcSEcCtD
Albendazole—Neutropenia—Dactinomycin—kidney cancer	0.000396	0.00505	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Sunitinib—kidney cancer	0.000396	0.00504	CcSEcCtD
Albendazole—Hepatobiliary disease—Sorafenib—kidney cancer	0.000392	0.005	CcSEcCtD
Albendazole—Erythema multiforme—Erlotinib—kidney cancer	0.000391	0.00499	CcSEcCtD
Albendazole—Immune system disorder—Everolimus—kidney cancer	0.000387	0.00494	CcSEcCtD
Albendazole—Liver function test abnormal—Gemcitabine—kidney cancer	0.000384	0.00489	CcSEcCtD
Albendazole—CYP3A4—renal system—kidney cancer	0.000382	0.0179	CbGeAlD
Albendazole—Alopecia—Vinblastine—kidney cancer	0.00038	0.00485	CcSEcCtD
Albendazole—Alopecia—Everolimus—kidney cancer	0.000379	0.00483	CcSEcCtD
Albendazole—Thrombocytopenia—Pazopanib—kidney cancer	0.000378	0.00482	CcSEcCtD
Albendazole—Hepatobiliary disease—Sunitinib—kidney cancer	0.000377	0.00481	CcSEcCtD
Albendazole—Renal failure acute—Paclitaxel—kidney cancer	0.000377	0.0048	CcSEcCtD
Albendazole—Skin disorder—Pazopanib—kidney cancer	0.000375	0.00478	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Dactinomycin—kidney cancer	0.000375	0.00477	CcSEcCtD
Albendazole—CYP3A4—kidney—kidney cancer	0.000369	0.0173	CbGeAlD
Albendazole—Urinary tract disorder—Sorafenib—kidney cancer	0.000368	0.00469	CcSEcCtD
Albendazole—Alopecia—Erlotinib—kidney cancer	0.000366	0.00466	CcSEcCtD
Albendazole—Urethral disorder—Sorafenib—kidney cancer	0.000365	0.00465	CcSEcCtD
Albendazole—Pancytopenia—Vincristine—kidney cancer	0.00036	0.00458	CcSEcCtD
Albendazole—Hepatitis—Sunitinib—kidney cancer	0.000358	0.00457	CcSEcCtD
Albendazole—Neutropenia—Vincristine—kidney cancer	0.000354	0.00451	CcSEcCtD
Albendazole—Urinary tract disorder—Sunitinib—kidney cancer	0.000354	0.00451	CcSEcCtD
Albendazole—Agranulocytosis—Dactinomycin—kidney cancer	0.000353	0.00449	CcSEcCtD
Albendazole—Erythema multiforme—Sorafenib—kidney cancer	0.000352	0.00449	CcSEcCtD
Albendazole—Urethral disorder—Sunitinib—kidney cancer	0.000351	0.00448	CcSEcCtD
Albendazole—Pancytopenia—Gemcitabine—kidney cancer	0.000341	0.00435	CcSEcCtD
Albendazole—Hepatitis—Dactinomycin—kidney cancer	0.000339	0.00432	CcSEcCtD
Albendazole—Erythema multiforme—Sunitinib—kidney cancer	0.000339	0.00432	CcSEcCtD
Albendazole—Vertigo—Vinblastine—kidney cancer	0.000337	0.00429	CcSEcCtD
Albendazole—Immune system disorder—Sorafenib—kidney cancer	0.000336	0.00429	CcSEcCtD
Albendazole—Neutropenia—Gemcitabine—kidney cancer	0.000336	0.00428	CcSEcCtD
Albendazole—Leukopenia—Vinblastine—kidney cancer	0.000335	0.00428	CcSEcCtD
Albendazole—Gastrointestinal pain—Temsirolimus—kidney cancer	0.000335	0.00427	CcSEcCtD
Albendazole—Leukopenia—Everolimus—kidney cancer	0.000334	0.00426	CcSEcCtD
Albendazole—Alopecia—Sorafenib—kidney cancer	0.000329	0.00419	CcSEcCtD
Albendazole—Body temperature increased—Temsirolimus—kidney cancer	0.000324	0.00413	CcSEcCtD
Albendazole—Abdominal pain—Temsirolimus—kidney cancer	0.000324	0.00413	CcSEcCtD
Albendazole—Immune system disorder—Sunitinib—kidney cancer	0.000324	0.00412	CcSEcCtD
Albendazole—Liver function test abnormal—Paclitaxel—kidney cancer	0.000321	0.00409	CcSEcCtD
Albendazole—Erythema multiforme—Dactinomycin—kidney cancer	0.000321	0.00409	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.000317	0.00405	CcSEcCtD
Albendazole—Alopecia—Sunitinib—kidney cancer	0.000317	0.00403	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.000316	0.00402	CcSEcCtD
Albendazole—Gastrointestinal pain—Pazopanib—kidney cancer	0.000316	0.00402	CcSEcCtD
Albendazole—Renal failure acute—Capecitabine—kidney cancer	0.000309	0.00394	CcSEcCtD
Albendazole—Abdominal pain—Pazopanib—kidney cancer	0.000305	0.00389	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.000305	0.00388	CcSEcCtD
Albendazole—Hepatobiliary disease—Gemcitabine—kidney cancer	0.000303	0.00386	CcSEcCtD
Albendazole—Hypersensitivity—Temsirolimus—kidney cancer	0.000302	0.00385	CcSEcCtD
Albendazole—Alopecia—Dactinomycin—kidney cancer	0.0003	0.00382	CcSEcCtD
Albendazole—Thrombocytopenia—Vinblastine—kidney cancer	0.0003	0.00382	CcSEcCtD
Albendazole—Urinary tract disorder—Vincristine—kidney cancer	0.000299	0.00381	CcSEcCtD
Albendazole—Agranulocytosis—Gemcitabine—kidney cancer	0.000299	0.00381	CcSEcCtD
Albendazole—Thrombocytopenia—Everolimus—kidney cancer	0.000298	0.0038	CcSEcCtD
Albendazole—ABCB1—nephron tubule—kidney cancer	0.000297	0.014	CbGeAlD
Albendazole—Urethral disorder—Vincristine—kidney cancer	0.000297	0.00379	CcSEcCtD
Albendazole—Skin disorder—Everolimus—kidney cancer	0.000296	0.00377	CcSEcCtD
Albendazole—Leukopenia—Sorafenib—kidney cancer	0.00029	0.0037	CcSEcCtD
Albendazole—Thrombocytopenia—Erlotinib—kidney cancer	0.000288	0.00367	CcSEcCtD
Albendazole—Skin disorder—Erlotinib—kidney cancer	0.000286	0.00364	CcSEcCtD
Albendazole—Pancytopenia—Paclitaxel—kidney cancer	0.000286	0.00364	CcSEcCtD
Albendazole—Urinary tract disorder—Gemcitabine—kidney cancer	0.000284	0.00362	CcSEcCtD
Albendazole—Urethral disorder—Gemcitabine—kidney cancer	0.000282	0.00359	CcSEcCtD
Albendazole—Neutropenia—Paclitaxel—kidney cancer	0.000281	0.00358	CcSEcCtD
Albendazole—Leukopenia—Sunitinib—kidney cancer	0.000279	0.00356	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000274	0.00349	CcSEcCtD
Albendazole—Erythema multiforme—Gemcitabine—kidney cancer	0.000272	0.00346	CcSEcCtD
Albendazole—Dizziness—Temsirolimus—kidney cancer	0.000271	0.00345	CcSEcCtD
Albendazole—ABCB1—renal system—kidney cancer	0.00027	0.0127	CbGeAlD
Albendazole—Alopecia—Vincristine—kidney cancer	0.000268	0.00341	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000266	0.00339	CcSEcCtD
Albendazole—Leukopenia—Dactinomycin—kidney cancer	0.000264	0.00337	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000264	0.00336	CcSEcCtD
Albendazole—Liver function test abnormal—Capecitabine—kidney cancer	0.000264	0.00336	CcSEcCtD
Albendazole—ABCB1—kidney—kidney cancer	0.000261	0.0123	CbGeAlD
Albendazole—Vomiting—Temsirolimus—kidney cancer	0.00026	0.00332	CcSEcCtD
Albendazole—Immune system disorder—Gemcitabine—kidney cancer	0.00026	0.00331	CcSEcCtD
Albendazole—Thrombocytopenia—Sorafenib—kidney cancer	0.000259	0.0033	CcSEcCtD
Albendazole—Rash—Temsirolimus—kidney cancer	0.000258	0.00329	CcSEcCtD
Albendazole—Dermatitis—Temsirolimus—kidney cancer	0.000258	0.00329	CcSEcCtD
Albendazole—Skin disorder—Sorafenib—kidney cancer	0.000257	0.00327	CcSEcCtD
Albendazole—Headache—Temsirolimus—kidney cancer	0.000257	0.00327	CcSEcCtD
Albendazole—Dizziness—Pazopanib—kidney cancer	0.000255	0.00325	CcSEcCtD
Albendazole—ABCB1—cortex of kidney—kidney cancer	0.000255	0.012	CbGeAlD
Albendazole—Alopecia—Gemcitabine—kidney cancer	0.000254	0.00324	CcSEcCtD
Albendazole—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000254	0.00323	CcSEcCtD
Albendazole—Gastrointestinal pain—Vinblastine—kidney cancer	0.00025	0.00319	CcSEcCtD
Albendazole—Thrombocytopenia—Sunitinib—kidney cancer	0.000249	0.00318	CcSEcCtD
Albendazole—Gastrointestinal pain—Everolimus—kidney cancer	0.000249	0.00318	CcSEcCtD
Albendazole—Skin disorder—Sunitinib—kidney cancer	0.000247	0.00315	CcSEcCtD
Albendazole—Vomiting—Pazopanib—kidney cancer	0.000245	0.00313	CcSEcCtD
Albendazole—Rash—Pazopanib—kidney cancer	0.000243	0.0031	CcSEcCtD
Albendazole—Nausea—Temsirolimus—kidney cancer	0.000243	0.0031	CcSEcCtD
Albendazole—Dermatitis—Pazopanib—kidney cancer	0.000243	0.0031	CcSEcCtD
Albendazole—ABCB1—gonad—kidney cancer	0.000242	0.0114	CbGeAlD
Albendazole—Abdominal pain—Vinblastine—kidney cancer	0.000242	0.00308	CcSEcCtD
Albendazole—Headache—Pazopanib—kidney cancer	0.000242	0.00308	CcSEcCtD
Albendazole—Body temperature increased—Everolimus—kidney cancer	0.000241	0.00307	CcSEcCtD
Albendazole—Abdominal pain—Everolimus—kidney cancer	0.000241	0.00307	CcSEcCtD
Albendazole—Gastrointestinal pain—Erlotinib—kidney cancer	0.00024	0.00306	CcSEcCtD
Albendazole—Aplastic anaemia—Doxorubicin—kidney cancer	0.000238	0.00303	CcSEcCtD
Albendazole—Urinary tract disorder—Paclitaxel—kidney cancer	0.000238	0.00303	CcSEcCtD
Albendazole—Vertigo—Vincristine—kidney cancer	0.000237	0.00302	CcSEcCtD
Albendazole—Leukopenia—Vincristine—kidney cancer	0.000236	0.00301	CcSEcCtD
Albendazole—Urethral disorder—Paclitaxel—kidney cancer	0.000236	0.00301	CcSEcCtD
Albendazole—Thrombocytopenia—Dactinomycin—kidney cancer	0.000236	0.00301	CcSEcCtD
Albendazole—Pancytopenia—Capecitabine—kidney cancer	0.000234	0.00299	CcSEcCtD
Albendazole—Abdominal pain—Erlotinib—kidney cancer	0.000232	0.00296	CcSEcCtD
Albendazole—Body temperature increased—Erlotinib—kidney cancer	0.000232	0.00296	CcSEcCtD
Albendazole—Neutropenia—Capecitabine—kidney cancer	0.000231	0.00294	CcSEcCtD
Albendazole—Nausea—Pazopanib—kidney cancer	0.000229	0.00292	CcSEcCtD
Albendazole—Erythema multiforme—Paclitaxel—kidney cancer	0.000228	0.0029	CcSEcCtD
Albendazole—Hypersensitivity—Vinblastine—kidney cancer	0.000225	0.00287	CcSEcCtD
Albendazole—Hypersensitivity—Everolimus—kidney cancer	0.000225	0.00286	CcSEcCtD
Albendazole—Leukopenia—Gemcitabine—kidney cancer	0.000224	0.00285	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000218	0.00278	CcSEcCtD
Albendazole—Immune system disorder—Paclitaxel—kidney cancer	0.000217	0.00277	CcSEcCtD
Albendazole—Gastrointestinal pain—Sorafenib—kidney cancer	0.000216	0.00276	CcSEcCtD
Albendazole—Alopecia—Paclitaxel—kidney cancer	0.000213	0.00271	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000212	0.0027	CcSEcCtD
Albendazole—Thrombocytopenia—Vincristine—kidney cancer	0.000211	0.00269	CcSEcCtD
Albendazole—Urticaria—Sorafenib—kidney cancer	0.00021	0.00268	CcSEcCtD
Albendazole—Abdominal pain—Sorafenib—kidney cancer	0.000209	0.00266	CcSEcCtD
Albendazole—Body temperature increased—Sorafenib—kidney cancer	0.000209	0.00266	CcSEcCtD
Albendazole—Gastrointestinal pain—Sunitinib—kidney cancer	0.000208	0.00265	CcSEcCtD
Albendazole—Hepatobiliary disease—Capecitabine—kidney cancer	0.000208	0.00265	CcSEcCtD
Albendazole—Agranulocytosis—Capecitabine—kidney cancer	0.000205	0.00262	CcSEcCtD
Albendazole—Dizziness—Vinblastine—kidney cancer	0.000202	0.00258	CcSEcCtD
Albendazole—Dizziness—Everolimus—kidney cancer	0.000202	0.00257	CcSEcCtD
Albendazole—Body temperature increased—Sunitinib—kidney cancer	0.000201	0.00256	CcSEcCtD
Albendazole—Abdominal pain—Sunitinib—kidney cancer	0.000201	0.00256	CcSEcCtD
Albendazole—Thrombocytopenia—Gemcitabine—kidney cancer	0.0002	0.00255	CcSEcCtD
Albendazole—Renal failure acute—Doxorubicin—kidney cancer	0.000199	0.00254	CcSEcCtD
Albendazole—Skin disorder—Gemcitabine—kidney cancer	0.000198	0.00253	CcSEcCtD
Albendazole—Hepatitis—Capecitabine—kidney cancer	0.000198	0.00252	CcSEcCtD
Albendazole—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000197	0.00251	CcSEcCtD
Albendazole—Urinary tract disorder—Capecitabine—kidney cancer	0.000195	0.00249	CcSEcCtD
Albendazole—Hypersensitivity—Sorafenib—kidney cancer	0.000195	0.00248	CcSEcCtD
Albendazole—Vomiting—Vinblastine—kidney cancer	0.000194	0.00248	CcSEcCtD
Albendazole—Dizziness—Erlotinib—kidney cancer	0.000194	0.00248	CcSEcCtD
Albendazole—Vomiting—Everolimus—kidney cancer	0.000194	0.00247	CcSEcCtD
Albendazole—Urethral disorder—Capecitabine—kidney cancer	0.000194	0.00247	CcSEcCtD
Albendazole—Rash—Everolimus—kidney cancer	0.000192	0.00245	CcSEcCtD
Albendazole—Dermatitis—Everolimus—kidney cancer	0.000192	0.00245	CcSEcCtD
Albendazole—Headache—Vinblastine—kidney cancer	0.000192	0.00244	CcSEcCtD
Albendazole—Headache—Everolimus—kidney cancer	0.000191	0.00243	CcSEcCtD
Albendazole—Abdominal pain—Dactinomycin—kidney cancer	0.00019	0.00243	CcSEcCtD
Albendazole—Body temperature increased—Dactinomycin—kidney cancer	0.00019	0.00243	CcSEcCtD
Albendazole—Vertigo—Paclitaxel—kidney cancer	0.000188	0.0024	CcSEcCtD
Albendazole—Leukopenia—Paclitaxel—kidney cancer	0.000188	0.00239	CcSEcCtD
Albendazole—Hypersensitivity—Sunitinib—kidney cancer	0.000188	0.00239	CcSEcCtD
Albendazole—Vomiting—Erlotinib—kidney cancer	0.000187	0.00238	CcSEcCtD
Albendazole—Erythema multiforme—Capecitabine—kidney cancer	0.000187	0.00238	CcSEcCtD
Albendazole—Rash—Erlotinib—kidney cancer	0.000185	0.00236	CcSEcCtD
Albendazole—Dermatitis—Erlotinib—kidney cancer	0.000185	0.00236	CcSEcCtD
Albendazole—Headache—Erlotinib—kidney cancer	0.000184	0.00235	CcSEcCtD
Albendazole—Nausea—Vinblastine—kidney cancer	0.000182	0.00232	CcSEcCtD
Albendazole—Nausea—Everolimus—kidney cancer	0.000181	0.00231	CcSEcCtD
Albendazole—Immune system disorder—Capecitabine—kidney cancer	0.000178	0.00227	CcSEcCtD
Albendazole—Hypersensitivity—Dactinomycin—kidney cancer	0.000178	0.00226	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000177	0.00226	CcSEcCtD
Albendazole—Gastrointestinal pain—Vincristine—kidney cancer	0.000176	0.00224	CcSEcCtD
Albendazole—Dizziness—Sorafenib—kidney cancer	0.000175	0.00223	CcSEcCtD
Albendazole—Nausea—Erlotinib—kidney cancer	0.000175	0.00223	CcSEcCtD
Albendazole—Alopecia—Capecitabine—kidney cancer	0.000175	0.00222	CcSEcCtD
Albendazole—Abdominal pain—Vincristine—kidney cancer	0.00017	0.00217	CcSEcCtD
Albendazole—Body temperature increased—Vincristine—kidney cancer	0.00017	0.00217	CcSEcCtD
Albendazole—Liver function test abnormal—Doxorubicin—kidney cancer	0.00017	0.00217	CcSEcCtD
Albendazole—Dizziness—Sunitinib—kidney cancer	0.000168	0.00214	CcSEcCtD
Albendazole—Vomiting—Sorafenib—kidney cancer	0.000168	0.00214	CcSEcCtD
Albendazole—Thrombocytopenia—Paclitaxel—kidney cancer	0.000167	0.00213	CcSEcCtD
Albendazole—Rash—Sorafenib—kidney cancer	0.000167	0.00213	CcSEcCtD
Albendazole—Dermatitis—Sorafenib—kidney cancer	0.000167	0.00212	CcSEcCtD
Albendazole—Skin disorder—Paclitaxel—kidney cancer	0.000166	0.00212	CcSEcCtD
Albendazole—Headache—Sorafenib—kidney cancer	0.000166	0.00211	CcSEcCtD
Albendazole—Vomiting—Sunitinib—kidney cancer	0.000162	0.00206	CcSEcCtD
Albendazole—Body temperature increased—Gemcitabine—kidney cancer	0.000161	0.00206	CcSEcCtD
Albendazole—Rash—Sunitinib—kidney cancer	0.00016	0.00205	CcSEcCtD
Albendazole—Dermatitis—Sunitinib—kidney cancer	0.00016	0.00204	CcSEcCtD
Albendazole—Headache—Sunitinib—kidney cancer	0.000159	0.00203	CcSEcCtD
Albendazole—Hypersensitivity—Vincristine—kidney cancer	0.000159	0.00202	CcSEcCtD
Albendazole—Nausea—Sorafenib—kidney cancer	0.000157	0.002	CcSEcCtD
Albendazole—Vertigo—Capecitabine—kidney cancer	0.000154	0.00197	CcSEcCtD
Albendazole—Leukopenia—Capecitabine—kidney cancer	0.000154	0.00196	CcSEcCtD
Albendazole—Vomiting—Dactinomycin—kidney cancer	0.000153	0.00195	CcSEcCtD
Albendazole—Rash—Dactinomycin—kidney cancer	0.000152	0.00194	CcSEcCtD
Albendazole—Nausea—Sunitinib—kidney cancer	0.000151	0.00193	CcSEcCtD
Albendazole—Pancytopenia—Doxorubicin—kidney cancer	0.000151	0.00192	CcSEcCtD
Albendazole—Neutropenia—Doxorubicin—kidney cancer	0.000149	0.0019	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000145	0.00185	CcSEcCtD
Albendazole—Nausea—Dactinomycin—kidney cancer	0.000143	0.00182	CcSEcCtD
Albendazole—Dizziness—Vincristine—kidney cancer	0.000142	0.00181	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000141	0.00179	CcSEcCtD
Albendazole—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00014	0.00178	CcSEcCtD
Albendazole—Thrombocytopenia—Capecitabine—kidney cancer	0.000137	0.00175	CcSEcCtD
Albendazole—Vomiting—Vincristine—kidney cancer	0.000137	0.00174	CcSEcCtD
Albendazole—Skin disorder—Capecitabine—kidney cancer	0.000136	0.00174	CcSEcCtD
Albendazole—Urticaria—Paclitaxel—kidney cancer	0.000136	0.00173	CcSEcCtD
Albendazole—Rash—Vincristine—kidney cancer	0.000136	0.00173	CcSEcCtD
Albendazole—Dermatitis—Vincristine—kidney cancer	0.000136	0.00173	CcSEcCtD
Albendazole—Body temperature increased—Paclitaxel—kidney cancer	0.000135	0.00172	CcSEcCtD
Albendazole—Abdominal pain—Paclitaxel—kidney cancer	0.000135	0.00172	CcSEcCtD
Albendazole—Headache—Vincristine—kidney cancer	0.000135	0.00172	CcSEcCtD
Albendazole—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000134	0.00171	CcSEcCtD
Albendazole—Agranulocytosis—Doxorubicin—kidney cancer	0.000132	0.00169	CcSEcCtD
Albendazole—Vomiting—Gemcitabine—kidney cancer	0.00013	0.00165	CcSEcCtD
Albendazole—Rash—Gemcitabine—kidney cancer	0.000129	0.00164	CcSEcCtD
Albendazole—Dermatitis—Gemcitabine—kidney cancer	0.000129	0.00164	CcSEcCtD
Albendazole—Headache—Gemcitabine—kidney cancer	0.000128	0.00163	CcSEcCtD
Albendazole—Nausea—Vincristine—kidney cancer	0.000128	0.00163	CcSEcCtD
Albendazole—Hepatitis—Doxorubicin—kidney cancer	0.000127	0.00162	CcSEcCtD
Albendazole—Hypersensitivity—Paclitaxel—kidney cancer	0.000126	0.00161	CcSEcCtD
Albendazole—Urinary tract disorder—Doxorubicin—kidney cancer	0.000126	0.0016	CcSEcCtD
Albendazole—Urethral disorder—Doxorubicin—kidney cancer	0.000125	0.00159	CcSEcCtD
Albendazole—Nausea—Gemcitabine—kidney cancer	0.000121	0.00155	CcSEcCtD
Albendazole—Erythema multiforme—Doxorubicin—kidney cancer	0.00012	0.00153	CcSEcCtD
Albendazole—Immune system disorder—Doxorubicin—kidney cancer	0.000115	0.00147	CcSEcCtD
Albendazole—Gastrointestinal pain—Capecitabine—kidney cancer	0.000115	0.00146	CcSEcCtD
Albendazole—Dizziness—Paclitaxel—kidney cancer	0.000113	0.00144	CcSEcCtD
Albendazole—Alopecia—Doxorubicin—kidney cancer	0.000112	0.00143	CcSEcCtD
Albendazole—Urticaria—Capecitabine—kidney cancer	0.000111	0.00142	CcSEcCtD
Albendazole—Abdominal pain—Capecitabine—kidney cancer	0.000111	0.00141	CcSEcCtD
Albendazole—Body temperature increased—Capecitabine—kidney cancer	0.000111	0.00141	CcSEcCtD
Albendazole—Vomiting—Paclitaxel—kidney cancer	0.000109	0.00139	CcSEcCtD
Albendazole—Rash—Paclitaxel—kidney cancer	0.000108	0.00137	CcSEcCtD
Albendazole—Dermatitis—Paclitaxel—kidney cancer	0.000108	0.00137	CcSEcCtD
Albendazole—Headache—Paclitaxel—kidney cancer	0.000107	0.00137	CcSEcCtD
Albendazole—Hypersensitivity—Capecitabine—kidney cancer	0.000103	0.00132	CcSEcCtD
Albendazole—Nausea—Paclitaxel—kidney cancer	0.000102	0.00129	CcSEcCtD
Albendazole—Vertigo—Doxorubicin—kidney cancer	9.96e-05	0.00127	CcSEcCtD
Albendazole—Leukopenia—Doxorubicin—kidney cancer	9.92e-05	0.00126	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	9.37e-05	0.00119	CcSEcCtD
Albendazole—Dizziness—Capecitabine—kidney cancer	9.28e-05	0.00118	CcSEcCtD
Albendazole—Vomiting—Capecitabine—kidney cancer	8.92e-05	0.00114	CcSEcCtD
Albendazole—Thrombocytopenia—Doxorubicin—kidney cancer	8.86e-05	0.00113	CcSEcCtD
Albendazole—Rash—Capecitabine—kidney cancer	8.85e-05	0.00113	CcSEcCtD
Albendazole—Dermatitis—Capecitabine—kidney cancer	8.84e-05	0.00113	CcSEcCtD
Albendazole—Headache—Capecitabine—kidney cancer	8.79e-05	0.00112	CcSEcCtD
Albendazole—Skin disorder—Doxorubicin—kidney cancer	8.79e-05	0.00112	CcSEcCtD
Albendazole—Nausea—Capecitabine—kidney cancer	8.33e-05	0.00106	CcSEcCtD
Albendazole—Gastrointestinal pain—Doxorubicin—kidney cancer	7.4e-05	0.000943	CcSEcCtD
Albendazole—Urticaria—Doxorubicin—kidney cancer	7.19e-05	0.000916	CcSEcCtD
Albendazole—Abdominal pain—Doxorubicin—kidney cancer	7.15e-05	0.000911	CcSEcCtD
Albendazole—Body temperature increased—Doxorubicin—kidney cancer	7.15e-05	0.000911	CcSEcCtD
Albendazole—Hypersensitivity—Doxorubicin—kidney cancer	6.66e-05	0.000849	CcSEcCtD
Albendazole—Dizziness—Doxorubicin—kidney cancer	5.98e-05	0.000762	CcSEcCtD
Albendazole—Vomiting—Doxorubicin—kidney cancer	5.75e-05	0.000733	CcSEcCtD
Albendazole—Rash—Doxorubicin—kidney cancer	5.7e-05	0.000727	CcSEcCtD
Albendazole—Dermatitis—Doxorubicin—kidney cancer	5.7e-05	0.000726	CcSEcCtD
Albendazole—Headache—Doxorubicin—kidney cancer	5.67e-05	0.000722	CcSEcCtD
Albendazole—Nausea—Doxorubicin—kidney cancer	5.37e-05	0.000685	CcSEcCtD
Albendazole—CYP1A2—Biological oxidations—GSTT1—kidney cancer	2.97e-05	0.0012	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—GSTM1—kidney cancer	2.97e-05	0.0012	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.93e-05	0.00118	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—CCND1—kidney cancer	2.93e-05	0.00118	CbGpPWpGaD
Albendazole—CYP1A1—Metapathway biotransformation—GSTM1—kidney cancer	2.93e-05	0.00118	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	2.9e-05	0.00117	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	2.9e-05	0.00117	CbGpPWpGaD
Albendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	2.87e-05	0.00115	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	2.84e-05	0.00114	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—BIRC5—kidney cancer	2.82e-05	0.00114	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	2.82e-05	0.00114	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	2.82e-05	0.00114	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—PTGS1—kidney cancer	2.78e-05	0.00112	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	2.76e-05	0.00111	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CDKN1B—kidney cancer	2.75e-05	0.00111	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—IGF2—kidney cancer	2.74e-05	0.0011	CbGpPWpGaD
Albendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	2.64e-05	0.00107	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	2.64e-05	0.00106	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—CCND1—kidney cancer	2.62e-05	0.00106	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.61e-05	0.00105	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	2.59e-05	0.00104	CbGpPWpGaD
Albendazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.52e-05	0.00101	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ACY1—kidney cancer	2.47e-05	0.000997	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	2.46e-05	0.000989	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—MAPK3—kidney cancer	2.42e-05	0.000973	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	2.41e-05	0.000972	CbGpPWpGaD
Albendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.4e-05	0.000966	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—MYC—kidney cancer	2.35e-05	0.000947	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	2.32e-05	0.000934	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—IL2—kidney cancer	2.31e-05	0.00093	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle, Mitotic—MAPK1—kidney cancer	2.3e-05	0.000926	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	2.3e-05	0.000926	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.29e-05	0.000924	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	2.26e-05	0.000913	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	2.22e-05	0.000895	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.22e-05	0.000893	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.22e-05	0.000893	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.22e-05	0.000893	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	2.17e-05	0.000875	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—CTNNB1—kidney cancer	2.16e-05	0.000871	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MAPK3—kidney cancer	2.16e-05	0.00087	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.15e-05	0.000866	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.11e-05	0.00085	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PDHB—kidney cancer	2.1e-05	0.000848	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MYC—kidney cancer	2.1e-05	0.000846	CbGpPWpGaD
Albendazole—CYP1A1—Biological oxidations—POMC—kidney cancer	2.1e-05	0.000845	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—kidney cancer	2.09e-05	0.000843	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTP1—kidney cancer	2.06e-05	0.00083	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MAPK1—kidney cancer	2.06e-05	0.000828	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	2.05e-05	0.000827	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	2.03e-05	0.000818	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CCBL1—kidney cancer	1.98e-05	0.000797	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ACY1—kidney cancer	1.98e-05	0.000796	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—VEGFA—kidney cancer	1.96e-05	0.00079	CbGpPWpGaD
Albendazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.94e-05	0.000783	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—GSTM1—kidney cancer	1.89e-05	0.000762	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN2A—kidney cancer	1.87e-05	0.000754	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	1.87e-05	0.000752	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1B—kidney cancer	1.85e-05	0.000747	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—POMC—kidney cancer	1.83e-05	0.000737	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	1.79e-05	0.000723	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.79e-05	0.000721	CbGpPWpGaD
Albendazole—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	1.77e-05	0.000713	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—kidney cancer	1.77e-05	0.000713	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—TP53—kidney cancer	1.73e-05	0.000695	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GLIPR1—kidney cancer	1.72e-05	0.000691	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPAT—kidney cancer	1.72e-05	0.000691	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.69e-05	0.000682	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PDHB—kidney cancer	1.68e-05	0.000677	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.68e-05	0.000675	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—RAF1—kidney cancer	1.66e-05	0.000669	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN1B—kidney cancer	1.66e-05	0.000668	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	1.62e-05	0.000652	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—FH—kidney cancer	1.59e-05	0.000642	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APRT—kidney cancer	1.59e-05	0.000642	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.59e-05	0.00064	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CCND1—kidney cancer	1.58e-05	0.000637	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CCBL1—kidney cancer	1.58e-05	0.000637	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ACY1—kidney cancer	1.58e-05	0.000636	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.57e-05	0.000631	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.56e-05	0.000628	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GPC3—kidney cancer	1.5e-05	0.000604	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.46e-05	0.000588	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MAPK3—kidney cancer	1.46e-05	0.000588	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CA2—kidney cancer	1.46e-05	0.000588	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.44e-05	0.00058	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALAD—kidney cancer	1.42e-05	0.000573	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MYC—kidney cancer	1.42e-05	0.000572	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MAPK1—kidney cancer	1.39e-05	0.000559	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ST3GAL2—kidney cancer	1.39e-05	0.000559	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.38e-05	0.000558	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GLIPR1—kidney cancer	1.37e-05	0.000552	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPAT—kidney cancer	1.37e-05	0.000552	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.37e-05	0.00055	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALDH1A1—kidney cancer	1.36e-05	0.000546	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.35e-05	0.000542	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PDHB—kidney cancer	1.34e-05	0.000541	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—POMC—kidney cancer	1.34e-05	0.000539	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CTNNB1—kidney cancer	1.31e-05	0.000526	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MAPK3—kidney cancer	1.3e-05	0.000525	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC5A3—kidney cancer	1.3e-05	0.000524	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PGK1—kidney cancer	1.3e-05	0.000524	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—LDHB—kidney cancer	1.27e-05	0.000514	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APRT—kidney cancer	1.27e-05	0.000513	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—FH—kidney cancer	1.27e-05	0.000513	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.27e-05	0.000512	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MYC—kidney cancer	1.27e-05	0.000511	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CCBL1—kidney cancer	1.26e-05	0.000508	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.26e-05	0.000506	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MAPK1—kidney cancer	1.24e-05	0.0005	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.23e-05	0.000495	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ACY1—kidney cancer	1.22e-05	0.000491	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GPC3—kidney cancer	1.2e-05	0.000482	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.17e-05	0.000471	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CA2—kidney cancer	1.16e-05	0.000469	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.16e-05	0.000469	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.14e-05	0.00046	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALAD—kidney cancer	1.14e-05	0.000457	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.13e-05	0.000455	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.11e-05	0.000447	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.11e-05	0.000446	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.11e-05	0.000446	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CA9—kidney cancer	1.11e-05	0.000445	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.1e-05	0.000443	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.09e-05	0.000441	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPAT—kidney cancer	1.09e-05	0.000441	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.08e-05	0.000436	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.08e-05	0.000435	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.07e-05	0.000432	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.07e-05	0.000431	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TP53—kidney cancer	1.04e-05	0.00042	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PGK1—kidney cancer	1.04e-05	0.000418	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC5A3—kidney cancer	1.04e-05	0.000418	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PDHB—kidney cancer	1.04e-05	0.000417	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—POMC—kidney cancer	1.03e-05	0.000416	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LDHB—kidney cancer	1.02e-05	0.00041	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APRT—kidney cancer	1.02e-05	0.00041	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—FH—kidney cancer	1.02e-05	0.00041	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	9.94e-06	0.0004	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CCBL1—kidney cancer	9.73e-06	0.000392	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	9.68e-06	0.00039	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPC3—kidney cancer	9.56e-06	0.000385	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CRABP1—kidney cancer	9.4e-06	0.000379	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CA2—kidney cancer	9.3e-06	0.000375	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	9.16e-06	0.000369	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALAD—kidney cancer	9.06e-06	0.000365	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	8.91e-06	0.000359	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ST3GAL2—kidney cancer	8.84e-06	0.000356	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CA9—kidney cancer	8.83e-06	0.000356	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ITPR2—kidney cancer	8.74e-06	0.000352	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	8.71e-06	0.000351	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALDH1A1—kidney cancer	8.64e-06	0.000348	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPAT—kidney cancer	8.44e-06	0.00034	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GLIPR1—kidney cancer	8.44e-06	0.00034	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC5A3—kidney cancer	8.29e-06	0.000334	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PGK1—kidney cancer	8.29e-06	0.000334	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	8.23e-06	0.000332	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LDHB—kidney cancer	8.13e-06	0.000327	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.05e-06	0.000325	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ACHE—kidney cancer	7.97e-06	0.000321	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTT1—kidney cancer	7.97e-06	0.000321	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APRT—kidney cancer	7.85e-06	0.000316	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—FH—kidney cancer	7.85e-06	0.000316	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	7.56e-06	0.000305	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SCARB1—kidney cancer	7.54e-06	0.000304	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CRABP1—kidney cancer	7.51e-06	0.000302	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS1—kidney cancer	7.47e-06	0.000301	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPC3—kidney cancer	7.38e-06	0.000297	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PSMD7—kidney cancer	7.32e-06	0.000295	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	7.31e-06	0.000295	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CA2—kidney cancer	7.18e-06	0.000289	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CA9—kidney cancer	7.05e-06	0.000284	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALAD—kidney cancer	6.99e-06	0.000282	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ITPR2—kidney cancer	6.98e-06	0.000281	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—BCHE—kidney cancer	6.94e-06	0.00028	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.89e-06	0.000278	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC5A5—kidney cancer	6.86e-06	0.000276	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.83e-06	0.000275	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.67e-06	0.000269	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC2A1—kidney cancer	6.62e-06	0.000267	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.42e-06	0.000259	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PGK1—kidney cancer	6.4e-06	0.000258	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.4e-06	0.000258	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTT1—kidney cancer	6.36e-06	0.000256	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ACHE—kidney cancer	6.36e-06	0.000256	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LDHB—kidney cancer	6.27e-06	0.000253	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SCARB1—kidney cancer	6.02e-06	0.000243	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CRABP1—kidney cancer	5.99e-06	0.000241	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS1—kidney cancer	5.96e-06	0.00024	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PSMD7—kidney cancer	5.85e-06	0.000236	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.6e-06	0.000226	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ITPR2—kidney cancer	5.57e-06	0.000224	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—BCHE—kidney cancer	5.54e-06	0.000223	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTP1—kidney cancer	5.52e-06	0.000223	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC5A5—kidney cancer	5.48e-06	0.000221	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CA9—kidney cancer	5.44e-06	0.000219	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC2A1—kidney cancer	5.29e-06	0.000213	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCB1—kidney cancer	5.23e-06	0.000211	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.14e-06	0.000207	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ACHE—kidney cancer	5.08e-06	0.000205	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTT1—kidney cancer	5.08e-06	0.000205	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTM1—kidney cancer	5.07e-06	0.000204	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	5.04e-06	0.000203	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SCARB1—kidney cancer	4.81e-06	0.000194	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS1—kidney cancer	4.76e-06	0.000192	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PSMD7—kidney cancer	4.67e-06	0.000188	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CRABP1—kidney cancer	4.62e-06	0.000186	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—BCHE—kidney cancer	4.43e-06	0.000178	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTP1—kidney cancer	4.41e-06	0.000178	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC5A5—kidney cancer	4.37e-06	0.000176	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ITPR2—kidney cancer	4.3e-06	0.000173	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC2A1—kidney cancer	4.22e-06	0.00017	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.1e-06	0.000165	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTM1—kidney cancer	4.05e-06	0.000163	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.95e-06	0.000159	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTT1—kidney cancer	3.92e-06	0.000158	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ACHE—kidney cancer	3.92e-06	0.000158	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1A1—kidney cancer	3.84e-06	0.000155	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SCARB1—kidney cancer	3.71e-06	0.00015	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS1—kidney cancer	3.67e-06	0.000148	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PSMD7—kidney cancer	3.6e-06	0.000145	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—POMC—kidney cancer	3.59e-06	0.000145	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.57e-06	0.000144	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTP1—kidney cancer	3.52e-06	0.000142	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—BCHE—kidney cancer	3.42e-06	0.000138	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.37e-06	0.000136	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCB1—kidney cancer	3.33e-06	0.000134	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.26e-06	0.000131	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTM1—kidney cancer	3.24e-06	0.00013	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.07e-06	0.000124	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—POMC—kidney cancer	2.86e-06	0.000115	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—kidney cancer	2.86e-06	0.000115	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTP1—kidney cancer	2.72e-06	0.000109	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCB1—kidney cancer	2.57e-06	0.000104	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.52e-06	0.000102	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM1—kidney cancer	2.5e-06	0.000101	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTEN—kidney cancer	2.5e-06	0.000101	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.37e-06	9.54e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—POMC—kidney cancer	2.29e-06	9.21e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—kidney cancer	2.29e-06	9.21e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTEN—kidney cancer	1.99e-06	8.03e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—kidney cancer	1.82e-06	7.35e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—POMC—kidney cancer	1.77e-06	7.11e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.76e-06	7.09e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTEN—kidney cancer	1.59e-06	6.41e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—kidney cancer	1.41e-06	5.67e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CA—kidney cancer	1.41e-06	5.66e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTEN—kidney cancer	1.23e-06	4.95e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.12e-06	4.52e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.66e-07	3.49e-05	CbGpPWpGaD
